Extracellular Vesicles (EVs), including exosomes, are emerging as promising natural nano-scale platforms for delivering nucleic acids, proteins, and small molecules. However, precision EV engineering has been challenging to date. Such technologies have also been largely inaccessible for a broader community due to technical complexities. Here, we discuss materials and methods to express biomolecules on EVs.

Protein scaffolds were developed and clinically proven to effectively load therapeutic proteins on the surface or lumen of EVs. Chemical linkers were developed to link nucleic acids or small molecules to the EV membrane while preserving their bioactivity and potency. Case studies and clinical data for each EV loading and linking technology will be presented. Technologies described here will be available to Pharma, Biotech and Academic communities under a Research License for broader access. They will also be available to therapeutics companies via contract development and manufacturing services for producing their engineered EVs.

Author: Devarshi Kapadia, Licensing Associate Director

You may also be interested in:
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center